Top compounds associated with response to TNPO2


Feature Type Standardized
Nominal ANOVA
mRNA NSC632839 CTRPv2 pan-cancer AAC 0.14 0.0001
mRNA TL-2-105 GDSC1000 pan-cancer AAC 0.13 0.0001
mRNA PD-0325901 GDSC1000 pan-cancer AAC -0.13 0.0001
mRNA Mitomycin-C CTRPv2 pan-cancer AAC 0.13 0.0001
mRNA ciclopirox CTRPv2 pan-cancer AAC 0.13 0.0001
mRNA SRT-1720 CTRPv2 pan-cancer AAC 0.15 0.0001
mRNA navitoclax:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.14 0.0001
mRNA carboplatin:etoposide (40:17 mol/mol) CTRPv2 pan-cancer AAC 0.12 0.0002
mRNA BRD-K26531177 CTRPv2 pan-cancer AAC 0.15 0.0002
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.13 0.0002
Download CSV